The Patent Finder

E. Z. Bioxcel Solutions PVT. Ltd.

Also on record
Records under this name other than patents E. Z. Bioxcel Solutions PVT. Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to E. Z. Bioxcel Solutions PVT. Ltd.

PatentTitleStatus Expires Confidence
US 12,138,247Non-Sedating Dexmedetomidine Treatment Regimens
In force
 · Medium confidence
In forceMedium confidence
US 11,786,508Use of Sublingual Dexmedetomidine for the Treatment of Agitation
In force
 · Low confidence
In forceLow confidence
US 11,839,604Use of Sublingual Dexmedetomidine for the Treatment of Agitation
In force
 · High confidence
In forceHigh confidence
US 11,931,340Use of Sublingual Dexmedetomidine for the Treatment of Agitation
In force
 · High confidence
In forceHigh confidence
US 10,792,246Film Formulations Containing Dexmedetomidine and Methods of Producing Them
In force
 · High confidence
In forceHigh confidence
US 11,478,422Film Formulations Containing Dexmedetomidine and Methods of Producing Them
In force
 · High confidence
In forceHigh confidence
US 11,497,711Film Formulations Containing Dexmedetomidine and Methods of Producing Them
In force
 · High confidence
In forceHigh confidence
US 11,517,524Film Formulations Containing Dexmedetomidine and Methods of Producing Them
In force
 · Low confidence
In forceLow confidence
US 11,559,484Film Formulations Containing Dexmedetomidine and Methods of Producing Them
In force
 · High confidence
In forceHigh confidence
US 11,806,429Film Formulations Containing Dexmedetomidine and Methods of Producing Them
In force
 · High confidence
In forceHigh confidence
10 of 32 records shown.
Pro members see all 32.
Pro members: see all 32 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited